Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3200
0.00 (0.00%)
Aug 28, 2026, 9:33 AM EST
Microbix Biosystems Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 7.16 | 12.11 | 12.96 | 11.61 | 13.49 | 9.99 |
Cash & Short-Term Investments | 7.16 | 12.11 | 12.96 | 11.61 | 13.49 | 9.99 |
Cash Growth | -40.85% | -6.56% | 11.69% | -13.95% | 35.07% | 10677.25% |
Accounts Receivable | 2.58 | 1.61 | 4.16 | 4.12 | 3.06 | 4.18 |
Other Receivables | - | - | 0.03 | 0.06 | 0.03 | 0.03 |
Receivables | 2.58 | 1.61 | 4.19 | 4.18 | 3.09 | 4.21 |
Inventory | 10.56 | 9.2 | 6.46 | 5.75 | 5.28 | 4.41 |
Prepaid Expenses | 0.86 | 0.66 | 0.64 | 0.77 | 0.55 | 0.5 |
Total Current Assets | 21.16 | 23.57 | 24.26 | 22.3 | 22.41 | 19.09 |
Property, Plant & Equipment | 9.53 | 10.1 | 9.62 | 8.93 | 8.91 | 8.08 |
Other Intangible Assets | 3.36 | 3.73 | 4.22 | 4.42 | 1.5 | 1.65 |
Other Long-Term Assets | - | - | - | - | 0.33 | - |
Total Assets | 34.06 | 37.41 | 38.1 | 35.65 | 33.15 | 28.83 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 1.7 | 1.98 | 2.66 | 2.08 | 1.83 | 1.79 |
Current Portion of Long-Term Debt | 0.01 | 0.01 | 0.11 | 0.11 | 0.11 | 2.45 |
Current Portion of Leases | 0.22 | 0.21 | 0.13 | 0.16 | 0.16 | 0.21 |
Current Unearned Revenue | 1.14 | 0.59 | 0.49 | 2 | 0.55 | 0.74 |
Other Current Liabilities | - | - | - | -0 | - | - |
Total Current Liabilities | 3.07 | 2.78 | 3.39 | 4.35 | 2.65 | 5.19 |
Long-Term Debt | 5.35 | 5.26 | 5.59 | 5.68 | 4.71 | 4.09 |
Long-Term Leases | 1.14 | 1.3 | 0.57 | 0.7 | 0.85 | 0.99 |
Long-Term Unearned Revenue | 0.23 | 0.29 | 0.25 | 0.3 | - | - |
Total Liabilities | 9.8 | 9.62 | 9.8 | 11.03 | 8.21 | 10.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 49.61 | 50.43 | 48.68 | 49.04 | 49.92 | 43.61 |
Additional Paid-In Capital | 11.42 | 10.72 | 10.73 | 10.22 | 9.62 | 10.7 |
Retained Earnings | -39.04 | -35.64 | -33.39 | -36.91 | -36.87 | -38.66 |
Comprehensive Income & Other | 2.27 | 2.27 | 2.27 | 2.27 | 2.27 | 2.9 |
Shareholders' Equity | 24.26 | 27.79 | 28.3 | 24.62 | 24.94 | 18.56 |
Total Liabilities & Equity | 34.06 | 37.41 | 38.1 | 35.65 | 33.15 | 28.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | 6.72 | 6.77 | 6.4 | 6.65 | 5.82 | 7.74 |
Net Cash (Debt) | 0.44 | 5.34 | 6.57 | 4.96 | 7.66 | 2.25 |
Net Cash Growth | -92.27% | -18.70% | 32.41% | -35.30% | 240.46% | - |
Net Cash Per Share | 0.00 | 0.04 | 0.05 | 0.04 | 0.05 | 0.02 |
Filing Date Shares Outstanding | 136.97 | 139.25 | 135.54 | 136.85 | 138.99 | 126.38 |
Total Common Shares Outstanding | 136.97 | 139.25 | 135.54 | 136.85 | 138.99 | 126.38 |
Working Capital | 18.09 | 20.8 | 20.87 | 17.95 | 19.76 | 13.9 |
Book Value Per Share | 0.18 | 0.20 | 0.21 | 0.18 | 0.18 | 0.15 |
Tangible Book Value | 20.9 | 24.06 | 24.08 | 20.2 | 23.44 | 16.9 |
Tangible Book Value Per Share | 0.15 | 0.17 | 0.18 | 0.15 | 0.17 | 0.13 |
Land | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 |
Buildings | 6.76 | 6.75 | 6.62 | 6.27 | 6.2 | 5.28 |
Machinery | 11.19 | 10.76 | 10.1 | 8.62 | 7.67 | 6.9 |